MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
3.110
-0.010
-0.32%
Opening 12:07 04/22 EDT
OPEN
3.160
PREV CLOSE
3.120
HIGH
3.160
LOW
3.010
VOLUME
28.58K
TURNOVER
0
52 WEEK HIGH
6.45
52 WEEK LOW
2.750
MARKET CAP
99.21M
P/E (TTM)
-9.0119
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ANIX last week (0415-0419)?
Weekly Report · 6h ago
ANIXA BIOSCIENCES WELCOMES CELEBRITY ONCOLOGIST DR. SANJAY JUNEJA TO ITS CANCER BUSINESS ADVISORY BOARD
Reuters · 4d ago
Press Release: Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Dr. Juneja is a board-certified hematologist and medical oncologist.
Dow Jones · 4d ago
Weekly Report: what happened at ANIX last week (0408-0412)?
Weekly Report · 04/15 10:10
Weekly Report: what happened at ANIX last week (0401-0405)?
Weekly Report · 04/08 10:13
Weekly Report: what happened at ANIX last week (0325-0329)?
Weekly Report · 04/01 10:12
Weekly Report: what happened at ANIX last week (0318-0322)?
Weekly Report · 03/25 10:14
Anixa Biosciences Stockholders Affirm Confidence and Oversight
TipRanks · 03/22 20:42
More
About ANIX
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.